Talks
Zongertinib Receives FDA Approval
March 2, 2026
Share
TTF Approved in Pancreatic Cancer
February 19, 2026
Share
Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial
February 9, 2026
Share
Tiragolumab in esophageal SCC?
December 31, 2025
Share
Tinengotinib in cholangiocarcinoma
December 18, 2025
Share
PAXG for periop chemo in pancreas cancer
December 18, 2025
Share
HERIZON-GEA-01 positive in HER2+ GEJ ca
December 1, 2025
Share
CLDN18.2 in pancreas ca
December 1, 2025
Share
How would I treat resectable GEJ cancer?
December 1, 2025
Share
duravalumab approved for GEJ ca
November 25, 2025
Share
is FGFR2b exp in GEJ ca a target?
November 22, 2025
Share
LEAP-012 - No further development?
November 3, 2025
Share
Role for IO in MSS colon cancer?
October 31, 2025
Share
OS results from MATTERHORN trial
October 30, 2025
Share
Does HIPEC/CRS help?
October 19, 2025
Share
HAI pumps in BTC?
October 15, 2025
Share
a new triplet for BRAFV600E mCRC?
August 31, 2025
Share
a potential new option in BTC?
August 31, 2025
Share
NCCN updates for early stage GE cancer?
August 27, 2025
Share
updated OS from Keynote 585
August 25, 2025
Share
CLDN18.2 and Prognostic Implications
August 9, 2025
Share
NUC-1031 Negative
August 1, 2025
Share
KEYNOTE-937 Negative
August 1, 2025
Share
Can we target CEACAM5 in CRC?
August 1, 2025
Share
LEAP-015 Negative
August 1, 2025
Share
HIMALAYA 5-year Median OS Results
July 31, 2025
Share
Imbrave-152 Negative
July 29, 2025
Share
Zanidatamab + chemo in HER2+ gastric ca
July 22, 2025
Share
Adjuvant therapy in BTC?
July 12, 2025
Share
FORTITUDE 101 positive
June 30, 2025
Share
structured exercise in colon cancer pts
June 30, 2025
Share
DESTINY GASTRIC -04 positive
June 26, 2025
Share
TTFs in treatment of PDAC?
June 23, 2025
Share
PIK3CA mutation testing in CRC
June 14, 2025
Share
ATOMIC trial (2/2)
June 5, 2025
Share
ATOMIC trial positive (1/2)
June 5, 2025
Share
MATTERHORN trial resulted
June 1, 2025
Share
OS results from BREAKWATER
May 30, 2025
Share
overall survival from CM577
May 23, 2025
Share
FDA approval of retifanlimab for anal ca
May 16, 2025
Share
tocilizumab in PDAC
May 13, 2025
Share
BREAKWATER and BRAFmCRC
May 9, 2025
Share
ASCO plenary preview part 2
April 25, 2025
Share
ASCO Plenary preview part 1
April 25, 2025
Share
HER2 overexpression in BTC
April 23, 2025
Share
zanidatamab approves in HER2 BTC
April 23, 2025
Share
FDA approval in BRAF v600e CRC
April 15, 2025
Share
FDA approval of ipi/nivo for dMMR CRC
April 8, 2025
Share
tovecimig meets primary endpoint in BTC
April 2, 2025
Share
cabozantinib new FDA approval for NET
March 28, 2025
Share
tislelizumab approved in ESCC
March 16, 2025
Share
Peri op IO + FLOT new std?
March 8, 2025
Share
Ipi/nivo approved by EMA, US next?
March 6, 2025
Share
DESTINY GASTRIC 04 positive
March 5, 2025
Share
zenocutuzumab FDA approval
February 25, 2025
Share
INNOVATION trial ASCO GI 25
February 25, 2025
Share
perioperative trmt for gastric cancer
February 11, 2025
Share
ODAC evaluation of PFS IN CODEBREAK200
December 29, 2023
Share
Tofacitinib in refractory ICI hepatitis
December 27, 2023
Share
BMS acquires Rayzebio
December 26, 2023
Share
Close button
Why are you reporting this TALK?